Xiangdong Li

7.2k total citations · 2 hit papers
196 papers, 4.9k citations indexed

About

Xiangdong Li is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiangdong Li has authored 196 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 37 papers in Cancer Research and 30 papers in Surgery. Recurrent topics in Xiangdong Li's work include Reproductive Biology and Fertility (17 papers), Cancer-related molecular mechanisms research (17 papers) and Estrogen and related hormone effects (13 papers). Xiangdong Li is often cited by papers focused on Reproductive Biology and Fertility (17 papers), Cancer-related molecular mechanisms research (17 papers) and Estrogen and related hormone effects (13 papers). Xiangdong Li collaborates with scholars based in China, Finland and Poland. Xiangdong Li's co-authors include Nafis A. Rahman, Xiru Li, George F. Gao, Sari Mäkelä, Ilpo Huhtaniemi, Risto Santti, Matti Poutanen, Yong Zhang, Zhi‐Ming Zhang and Zhizhan Xu and has published in prestigious journals such as Cell, Physical Review Letters and Journal of Biological Chemistry.

In The Last Decade

Xiangdong Li

182 papers receiving 4.8k citations

Hit Papers

Zika Virus Causes Testis ... 2016 2026 2019 2022 2016 2022 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiangdong Li 1.9k 958 620 601 537 196 4.9k
Na Wang 2.1k 1.1× 454 0.5× 540 0.9× 845 1.4× 605 1.1× 273 5.0k
Harsha Gowda 3.2k 1.7× 845 0.9× 445 0.7× 499 0.8× 565 1.1× 185 5.7k
Wenjing Wang 2.5k 1.3× 813 0.8× 512 0.8× 875 1.5× 508 0.9× 290 5.1k
Xiaofeng Li 4.5k 2.4× 1.8k 1.9× 369 0.6× 659 1.1× 714 1.3× 330 7.8k
Liang Li 3.2k 1.7× 1.0k 1.1× 229 0.4× 479 0.8× 867 1.6× 473 7.0k
Liu Z 4.9k 2.6× 818 0.9× 1.3k 2.1× 640 1.1× 493 0.9× 519 8.0k
Michael Hubank 3.0k 1.5× 474 0.5× 282 0.5× 655 1.1× 314 0.6× 128 5.2k
Xia Zhang 3.3k 1.7× 1.0k 1.1× 557 0.9× 2.4k 4.1× 1.1k 2.0× 235 8.3k
Kenichi Yoshida 4.2k 2.2× 1.1k 1.2× 251 0.4× 807 1.3× 784 1.5× 366 8.8k
Bertrand Perret 3.5k 1.8× 1.4k 1.5× 292 0.5× 995 1.7× 601 1.1× 148 7.1k

Countries citing papers authored by Xiangdong Li

Since Specialization
Citations

This map shows the geographic impact of Xiangdong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangdong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangdong Li more than expected).

Fields of papers citing papers by Xiangdong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangdong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangdong Li. The network helps show where Xiangdong Li may publish in the future.

Co-authorship network of co-authors of Xiangdong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangdong Li. A scholar is included among the top collaborators of Xiangdong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangdong Li. Xiangdong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahman, Nafis A., Marcin Chruściel, Donata Ponikwicka‐Tyszko, et al.. (2025). Hecate-FSHβ33-53C/S lytic peptide conjugate selectively kills targeted follicle stimulating hormone receptor (FSHR)-positive cancer cells. Biomedicine & Pharmacotherapy. 186. 118022–118022. 1 indexed citations
2.
Ponikwicka‐Tyszko, Donata, Piotr Bernaczyk, Mariusz Koda, et al.. (2024). Functional evidence for two distinct mechanisms of action of progesterone and selective progesterone receptor modulator on uterine leiomyomas. Fertility and Sterility. 122(2). 341–351. 5 indexed citations
4.
He, Tangtian, Jiawen Xie, Ling Jin, et al.. (2024). Seasonal dynamics of the phage-bacterium linkage and associated antibiotic resistome in airborne PM2.5 of urban areas. Environment International. 194. 109155–109155. 3 indexed citations
5.
Yang, Xudong & Xiangdong Li. (2024). Oncogenic role of RNA-binding protein GNL2 in glioma: Promotion of tumor development through enhancing protein synthesis. Oncology Letters. 28(1). 307–307. 1 indexed citations
6.
Ponikwicka‐Tyszko, Donata, Piotr Bernaczyk, Mariusz Koda, et al.. (2024). Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth. International Journal of Cancer. 155(10). 1846–1857. 1 indexed citations
7.
Han, Sheng, Xiangdong Li, Nan Xia, et al.. (2023). Myeloid Trem2 Dynamically Regulates the Induction and Resolution of Hepatic Ischemia-Reperfusion Injury Inflammation. International Journal of Molecular Sciences. 24(7). 6348–6348. 13 indexed citations
8.
Xiong, Yuyan, Ruijie Tang, Junyan Xu, et al.. (2022). Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair. Stem Cell Research & Therapy. 13(1). 63–63. 31 indexed citations
9.
Xiong, Yuyan, Ruijie Tang, Junyan Xu, et al.. (2022). Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway. Stem Cell Research & Therapy. 13(1). 289–289. 62 indexed citations
10.
Ponikwicka‐Tyszko, Donata, Piotr Bernaczyk, Xiangdong Li, et al.. (2021). Novel expression of zona pellucida 3 protein in normal testis; potential functional implications. Molecular and Cellular Endocrinology. 539. 111502–111502. 8 indexed citations
11.
Ponikwicka‐Tyszko, Donata, Marcin Chruściel, Piotr Bernaczyk, et al.. (2020). Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice. Cancers. 12(11). 3263–3263. 9 indexed citations
12.
Yu, Wanpeng, Jun Gao, Wenqiang Ma, et al.. (2019). MicroRNA‐487a‐3p functions as a new tumor suppressor in prostate cancer by targeting CCND1. Journal of Cellular Physiology. 235(2). 1588–1600. 28 indexed citations
13.
Li, Xiangdong, Pei Dong, Wensu Wei, et al.. (2019). Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1. American Journal Of Pathology. 189(6). 1284–1297. 13 indexed citations
14.
Yang, Yu‐Lin, et al.. (2018). Induction of immune tolerance and altered cytokine expression in skin transplantation recipients. The Kaohsiung Journal of Medical Sciences. 34(6). 330–334. 2 indexed citations
15.
Qu, Chen, et al.. (2017). Correlation between the expression of BRCA-1 and BAG-1 proteins in triple negative breast cancer and its sensitivity to platinum-based chemotherapy. Biomedical Research-tokyo. 28(15). 6654–6661. 1 indexed citations
16.
Li, Xiangdong, et al.. (2014). An assessment of late fixed functional treatment and the stability of Forsus appliance effects. Australasian Orthodontic Journal. 30(1). 2–10. 7 indexed citations
18.
Li, Xiangdong, et al.. (2013). Development of calibrating device of portable pulmonary function test apparatus. 1 indexed citations
19.
Lin, Wei, Nafis A. Rahman, Jian Lin, et al.. (2011). Molecular Mechanisms of Bladder Outlet Obstruction in Transgenic Male Mice Overexpressing Aromatase (Cyp19a1). American Journal Of Pathology. 178(3). 1233–1244. 17 indexed citations
20.
Li, Xiangdong. (2007). The Clinic Applied Value of Urine Fibronectin in Diagnosis of Bladder Transitional Cell Cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026